Diagnostics (Jun 2023)

Medication-Related Osteonecrosis of the Jaws: A Comparison of SICMF–SIPMO and AAOMS Guidelines

  • Davide De Cicco,
  • Ciro Emiliano Boschetti,
  • Mario Santagata,
  • Giuseppe Colella,
  • Samuel Staglianò,
  • Alexander Gaggl,
  • Gian Battista Bottini,
  • Rita Vitagliano,
  • Salvatore D’amato

DOI
https://doi.org/10.3390/diagnostics13132137
Journal volume & issue
Vol. 13, no. 13
p. 2137

Abstract

Read online

(1) Background: Medication-related osteonecrosis of the jaws (MRONJ) is an adverse drug reaction characterized by progressive bone disruption and necrosis in the mandibular and/or maxillary bones. It occurs in individuals who have received antiresorptive drugs without prior radiotherapy. Since its first reported cases in the USA in 2003, extensive literature has emerged worldwide, leading to significant advancements in understanding MRONJ’s pathogenesis and management. (2) Results: This article aims to compare the current national recommendations provided by the Italian Society of Maxillofacial Surgery (SICMF)/Italian Society of Oral Pathology and Medicine (SIPMO) and the American Association of Oral and Maxillofacial Surgeons (AAOMS). (3) Conclusions: Historically, the AAOMS advocated for a more conservative approach compared to the Italian guidelines. However, in their 2022 update, the AAOMS adopted a different perspective based on reported evidence, highlighting the advantages of early surgical treatment. Despite resolving some initial controversies, differences still exist between the two sets of recommendations, particularly regarding diagnosis and staging.

Keywords